Back to Search
Start Over
Tamoxifen and risk of contralateral breast cancer for \textitBRCA1 and \textitBRCA2 mutation carriers
- Source :
- Journal of clinical oncology, Journal of clinical oncology, 2013, 31, pp.3091--9. ⟨10.1200/JCO.2012.47.8313⟩, Journal of Clinical Oncology, Journal of Clinical Oncology, 2013, 31, pp.3091--9. ⟨10.1200/JCO.2012.47.8313⟩
- Publication Year :
- 2013
- Publisher :
- HAL CCSD, 2013.
- Subjects :
- [SDV]Life Sciences [q-bio]
Subjects
Details
- Language :
- English
- ISSN :
- 0732183X and 15277755
- Database :
- OpenAIRE
- Journal :
- Journal of clinical oncology, Journal of clinical oncology, 2013, 31, pp.3091--9. ⟨10.1200/JCO.2012.47.8313⟩, Journal of Clinical Oncology, Journal of Clinical Oncology, 2013, 31, pp.3091--9. ⟨10.1200/JCO.2012.47.8313⟩
- Accession number :
- edsair.dedup.wf.001..b294ecf9333ca2d39ce551db026664a8
- Full Text :
- https://doi.org/10.1200/JCO.2012.47.8313⟩